011170 — Lotte Chemical Balance Sheet
0.000.00%
Last trade - 00:00- KR₩5tn
- KR₩16tn
- KR₩20tn
Annual balance sheet for Lotte Chemical, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Interim Report | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 3,802,173 | 3,737,071 | 4,493,886 | 3,717,405 | 3,886,904 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,579,848 | 1,436,948 | 1,946,109 | 2,862,414 | 2,764,305 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 7,220,859 | 6,876,463 | 9,430,723 | 9,466,180 | 9,814,400 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 7,788,061 | 7,468,971 | 7,826,590 | 11,111,112 | 14,711,388 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 20,043,105 | 19,386,546 | 22,855,161 | 26,784,588 | 33,476,310 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2,740,030 | 2,867,691 | 4,579,149 | 6,384,043 | 6,523,538 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 6,838,706 | 6,540,030 | 8,456,898 | 12,339,212 | 17,933,183 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 13,204,399 | 12,846,516 | 14,398,263 | 14,445,376 | 15,543,127 |
| Total Liabilities & Shareholders' Equity | 20,043,105 | 19,386,546 | 22,855,161 | 26,784,588 | 33,476,310 |
| Total Common Shares Outstanding |